PMID- 12661417
OWN - NLM
STAT- MEDLINE
DCOM- 20030813
LR  - 20061115
IS  - 0032-5449 (Print)
IS  - 0032-5449 (Linking)
VI  - 56 Suppl
DP  - 2002
TI  - [Immunotherapy of intravenous immunoglobulin preparations in neurologic 
      diseases].
PG  - 69-83
AB  - Intravenous immunoglobulin (IVIG) has been used in a wide range of neurological 
      conditions. Clinical effect of IVIG has been shown in controlled trials in 
      patients with Guillain-Barre syndrome, chronic inflammatory demyelinating 
      polyneuropathy, multifocal motor neuropathy, dermatomyositis and recently in 
      multiple sclerosis. This article aims to provide clinicians with an overview of 
      the potential benefits of intravenous immunoglobulins in neurological practice.
FAU - Lewanska, Magdalena
AU  - Lewanska M
AD  - Klinika Neurologii Akademii Medycznej w Lodzi.
FAU - Selmaj, Krzysztof
AU  - Selmaj K
LA  - pol
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Immunoterapia dozylnymi preparatami immunoglobulin w chorobach neurologicznych.
PL  - Poland
TA  - Postepy Hig Med Dosw
JT  - Postepy higieny i medycyny doswiadczalnej
JID - 0421052
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Adult
MH  - Child
MH  - Chronic Disease
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Nervous System Diseases/*drug therapy
RF  - 108
EDAT- 2003/03/29 05:00
MHDA- 2003/08/14 05:00
CRDT- 2003/03/29 05:00
PHST- 2003/03/29 05:00 [pubmed]
PHST- 2003/08/14 05:00 [medline]
PHST- 2003/03/29 05:00 [entrez]
PST - ppublish
SO  - Postepy Hig Med Dosw. 2002;56 Suppl:69-83.